好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Results of a Phase I Trial of Pioglitazone in RRMS Patients
MS and Related Diseases
(-)
006
Authors/Disclosures
Claudia Kaiser, MD (MSD Merck, Sharp and Dohme) No disclosure on file
Eseosa Ighodaro, MD, PhD (Wake Forest University School of Medicine) Dr. Ighodaro has nothing to disclose.
Dinesh Shukla, MD (St. Charles Hospital) No disclosure on file
Julie Van Der Zee No disclosure on file
Glenn T. Stebbins, PhD (Rush University Medical Center) Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Demetrios D. Skias, MD (Neurology Jesse Brown VA) No disclosure on file
George Katsamakis, MD (Northwest Neurology Ltd) No disclosure on file
No disclosure on file
Dusan Stefoski, MD, FAAN No disclosure on file
No disclosure on file
Douglas R. Jeffery, MD, PhD (Lake Norman Neurology At Piedmont Health Care) No disclosure on file
No disclosure on file
Douglas Feinstein, MD (University of Illinois) No disclosure on file